The Bethesda System For Reporting Thyroid Cytop... ✭ «Top»

Before this system was finalized (originally around 2010 and updated in 2023), different laboratories used different terms to describe thyroid fine-needle aspiration (FNA) samples, causing confusion for clinicians. The Bethesda System was developed through an NIH-sponsored conference to create a common language.

Indeterminate; high risk of being a follicular tumor, often requiring surgery to differentiate. The Bethesda System for Reporting Thyroid Cytop...

It categorizes thyroid nodules into six distinct groups based on the fine needle aspiration cytology (FNAC) results, each associated with a specific risk of malignancy (RoM) and recommended management: Before this system was finalized (originally around 2010

High probability of cancer; often leads to surgery. VI: Malignant: Confirmed cancer cells. Key Benefits It categorizes thyroid nodules into six distinct groups

The (ROM) for each Bethesda category The 2023 updates to the system How it compares to the TIRADS system for imaging Let me know which area you'd like to explore further.